Skip to main content

Alkermes, Inc. investor investigation over possible securities laws violations

  • If you are an investor in shares of Alkermes, Inc. (NASDAQ:ALKS), and/or have any information relating to the investigation, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

After Alkermes, Inc. lost more than 30% in stock value an investigation on behalf of investors in Alkermes, Inc. (NASDAQ:ALKS) shares concerning potential violations of Federal Securities laws in connection with the New Drug Application for Alkermess diabetes drug BYDUREON was announced. The investigation by a law firm on behalf of investors in ALKS shares concerns whether Alkermes, I...



You must register (for free) or login to view the entire investigation.